Life Science Company News

Results 41 - 60 out of 500 displayed.
«  1  2 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Robbins Geller Rudman & Dowd LLP, Lieff Cabraser Heimann & Bernstein LLP, and Dugan Law Firm, APLC Announce a $78 Million Class Action Settlement for Third Party Payors That Paid or Reimbursed Costs for Prescription Opioids or Treatment Relat

Read more ››
By: PR Newswire Association LLC. - 15 Apr 2024

Emmaus Life Sciences Reports Delayed Filing of Annual Report

Read more ››
By: PR Newswire Association LLC. - 15 Apr 2024

4Front Ventures Reports Fourth Quarter and Full Year 2023 Financial Results

Read more ››
By: PR Newswire Association LLC. - 15 Apr 2024

Greystone Farm at Salem Awarded Benchmark's Annual "Circle Award" for Outstanding Resident & Family Satisfaction

Read more ››
By: PR Newswire Association LLC. - 15 Apr 2024

Benchmark at Rye Executive Director Receives Annual "President's Award"

Read more ››
By: PR Newswire Association LLC. - 15 Apr 2024

Whisper Woods of Smithtown Associate Receives Benchmark's Annual Compassionate Caregiver Award

Read more ››
By: PR Newswire Association LLC. - 15 Apr 2024

Myeloid Therapeutics to Participate in Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit

Read more ››
By: PR Newswire Association LLC. - 15 Apr 2024

UNCONDITIONAL TO PREMIERE AT EUROPEAN PARLIAMENT, HIGHLIGHTING ONE BILLION CAREGIVERS GLOBALLY

Read more ››
By: PR Newswire Association LLC. - 15 Apr 2024

CAR T-Cell Therapy for Non-Hodgkin's Lymphoma Market to Showcase Significant Growth at a CAGR of 15% by 2032 | DelveInsight

Read more ››
By: PR Newswire Association LLC. - 15 Apr 2024

MRI Systems Market size is set to grow by USD 2.49 billion from 2023-2027, increasing prevalence of diseases coupled with growing geriatric population boost the market, Technavio

Read more ››
By: PR Newswire Association LLC. - 15 Apr 2024

Neumora Therapeutics Announces Clinical Hold of Phase 1 NMRA-266 Study

Read more ››
By: GlobeNewswire - 15 Apr 2024

TFF Pharmaceuticals Announces Additional Positive Data from the Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial Following Oral Presentation at the ISHLT 44th Annual Late Breaking Clinical Science Abstract Sessions

Read more ››
By: GlobeNewswire - 15 Apr 2024

Ultragenyx Announces Positive Interim Phase 1/2 Data in Patients with Angelman Syndrome After Treatment with GTX-102

Read more ››
By: GlobeNewswire - 15 Apr 2024

Ocular Therapeutix™ Executive Chairman Pravin U. Dugel, MD Becomes President and CEO Antony Mattessich is Stepping Down as President and CEO

Read more ››
By: GlobeNewswire - 15 Apr 2024

Walden Biosciences Announces Positive Topline Data from Phase 1+ Clinical Study of WAL0921 in Development for Treatment of Kidney Diseases

Read more ››
By: GlobeNewswire - 15 Apr 2024

Nature Medicine Publishes Interim Results from Gritstone bio’s Phase 1/2 Study of “Off-the-Shelf” Neoantigen Vaccine Platform (SLATE)

Read more ››
By: GlobeNewswire - 15 Apr 2024

Eagle Pharmaceuticals to Present Additional Data from Phase III Trial Demonstrating Sustained Response of Amisulpride for the Rescue Treatment of Postoperative Nausea and Vomiting (PONV) at the Upcoming ASPAN 2024 National Conference in Orlando, Flor

Read more ››
By: GlobeNewswire - 15 Apr 2024

Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer

Read more ››
By: GlobeNewswire - 15 Apr 2024

UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates

Read more ››
By: GlobeNewswire - 15 Apr 2024

Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer

Read more ››
By: GlobeNewswire - 15 Apr 2024
Results 41 - 60 out of 500 displayed.
«  1  2 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate